New blood-drug monitoring platform receives €10M funding
The platform will first be used to measure the concentration of beta-lactam antibiotics – used to treat or prevent bacterial infections – in a patient’s blood. (Image: Pexels/Karolina Grabowska)
The platform, which employs therapeutic drug monitoring and optical technology, could pave the way for personalised and faster care
Welcome to Electro optics
Already registered? Sign in to continue reading
Not got an account? Register for free to continue reading
